Literature DB >> 3931730

The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues.

M M Caramona, P Soares-da-Silva.   

Abstract

Dopamine, noradrenaline (NA) and adrenaline (Ad) depletion by 6-hydroxydopamine (6-OHDA) and pargyline plus 6-OHDA was investigated in the cat left ventricle, mesenteric and renal arteries, renal cortex, renal medulla and adrenal medulla. Catecholamine concentrations in plasma were also analyzed in these two experimental conditions. 6-OHDA alone or in combination with pargyline induced parallel decreases of NA and dopamine contents in the left ventricle. In the main trunk and proximal branches of the mesenteric artery and renal artery 6-OHDA selectively reduced NA without a parallel decrease in dopamine content. Previous treatment with pargyline abolished this selectivity. In the kidney of control animals, dopamine content was greater than could be attributed to its presence only in noradrenergic neurones. In the renal cortex 6-OHDA reduced significantly dopamine and NA contents, and in the renal medulla only NA levels were decreased by this drug. Pargyline plus 6-OHDA did not deplete the NA content either in the renal cortex or in the renal medulla, and only reduced significantly the dopamine content in the renal cortex. NA concentrations in plasma were increased by pargyline plus 6-OHDA whilst Ad remained unaffected. In the adrenal medulla only NA content was reduced either by 6-OHDA or pargyline plus 6-OHDA. The present findings suggest a NA-independent dopamine pool in both segments of the mesenteric artery and renal artery but not in the left ventricle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931730      PMCID: PMC1916696          DOI: 10.1111/j.1476-5381.1985.tb08903.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART.

Authors:  M LEVITT; S SPECTOR; A SJOERDSMA; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1965-04       Impact factor: 4.030

2.  Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction.

Authors:  M F Lokhandwala; J P Buckley
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

Review 3.  Dopamine and norepinephrine in noradrenergic axons: a study in vivo of their precursor product relationship by mass fragmentography and radiochemistry.

Authors:  E Costa; A R Green; S H Koslow; H F LeFevre; A V Revuelta; C Wang
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

Review 4.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

Review 5.  Pharmacological actions of 6-hydroxydopamine.

Authors:  R M Kostrzewa; D M Jacobowitz
Journal:  Pharmacol Rev       Date:  1974-09       Impact factor: 25.468

6.  Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.

Authors:  G R Breese; T D Traylor
Journal:  J Pharmacol Exp Ther       Date:  1970-09       Impact factor: 4.030

7.  Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

Authors:  B K Yeh; J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

8.  The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat.

Authors:  S R Snider; O Almgren; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

9.  Tyrosine hydroxylase.

Authors:  S Udenfriend
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

10.  Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.

Authors:  F E Bloom; S Algeri; A Groppetti; A Revuelta; E Costa
Journal:  Science       Date:  1969-12-05       Impact factor: 47.728

View more
  6 in total

1.  A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

2.  Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

3.  Dopamine actions in vitro on enzyme and electrolyte secretion from normal and sympathectomized rat parotid glands.

Authors:  A Danielsson; R Henriksson; S Sundström; P Wester
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

4.  Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

5.  Is adrenaline released by sympathetic nerves in man?

Authors:  M Esler; G Eisenhofer; J Chin; G Jennings; I Meredith; H Cox; G Lambert; J Thompson; A Dart
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

6.  Neurotransmitter Switching Coupled to β-Adrenergic Signaling in Sympathetic Neurons in Prehypertensive States.

Authors:  Emma N Bardsley; Harvey Davis; Keith J Buckler; David J Paterson
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.